Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €93.71 EUR
Change Today +0.47 / 0.50%
Volume 1.3K
As of 1:36 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

cvs health corp (CVS) Snapshot

Open
€93.01
Previous Close
€93.24
Day High
€93.99
Day Low
€92.59
52 Week High
03/16/15 - €98.75
52 Week Low
05/2/14 - €50.86
Market Cap
106.4B
Average Volume 10 Days
694.7
EPS TTM
--
Shares Outstanding
1.1B
EX-Date
04/22/15
P/E TM
--
Dividend
€1.42
Dividend Yield
1.12%
Current Stock Chart for CVS HEALTH CORP (CVS)

cvs health corp (CVS) Details

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. The Pharmacy Services segment offers pharmacy benefit management services, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private organizations, other sponsors of health benefit plans, and individuals under the CVS/caremark Pharmacy Services, Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, Coram CVS/specialty, NovoLogix, and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. As of December 31, 2014, it operated 7,822 retail drugstores, 860 health care clinics, 17 onsite pharmacy stores, 27 retail specialty pharmacy stores, 11 specialty mail order pharmacies, 4 mail service dispensing pharmacies, and 86 branches, as well as 6 centers of excellence for infusion and enteral services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

137,800 Employees
Last Reported Date: 02/10/15
Founded in 1892

cvs health corp (CVS) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $1.4M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $825.0K
Executive Vice President and President of CVS...
Total Annual Compensation: $900.0K
Executive Vice President and President of CVS...
Total Annual Compensation: $850.0K
Chief Health Care Strategy Officer, Executive...
Total Annual Compensation: $670.0K
Compensation as of Fiscal Year 2014.

cvs health corp (CVS) Key Developments

Four Firms Interested in Cruz Verde

KKR & Co. L.P. (NYSE:KKR), The Carlyle Group LP (NasdaqGS:CG), CVS Health Corporation (NYSE:CVS) and Fomento Económico Mexicano, S.A.B de C.V (BMV:FEMSA UBD) are reportedly interested in Farmacias CruzVerde S.A. Their final offers will be received in late April 2015. The sale process is being handled by JPMorgan. The owners may decide not to sell 100% of the business.

CVS Health Corporation Provides Earnings Guidance for the 2015

CVS Health Corporation provided earnings guidance for the 2015. For the year, the company expects to deliver adjusted earnings per share in the range of $5.05 to $5.19 a share, up 12.5% to 15.6%. And The company expects to deliver free cash flow in the range of $5.9 billion to $6.2 billion.

CVS Health Corporation Elects Alecia A. DeCoudreaux to Serve on the Board

Effective March 5, 2015, the board of directors of CVS Health Corporation elected Alecia A. DeCoudreaux to serve on the Board. Ms. DeCoudreaux has been President of Mills College. Previously, Ms. DeCoudreaux served in a number of leadership roles at Eli Lilly and Company including as vice president and deputy general counsel, specialty legal team, from 2010-2011, vice president and general counsel, Lilly USA, from 2005-2009, and secretary and deputy general counsel of Eli Lilly from 1999-2005. During her 30-year career with Eli Lilly Ms. DeCoudreaux also previously served as an executive director of Lilly Research Laboratories, director of federal government relations, director of state government relations and director of community relations.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CVS:GR €93.71 EUR +0.47

CVS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Costco Wholesale Corp $148.12 USD +0.82
Express Scripts Holding Co $87.34 USD +0.45
Home Depot Inc/The $113.70 USD -0.26
UnitedHealth Group Inc $118.69 USD +0.43
Walgreens Boots Alliance Inc $85.98 USD -0.71
View Industry Companies
 

Industry Analysis

CVS

Industry Average

Valuation CVS Industry Range
Price/Earnings 25.7x
Price/Sales 0.8x
Price/Book 3.1x
Price/Cash Flow 24.8x
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CVS HEALTH CORP, please visit www.cvshealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.